ReviewFrontiers in cardiovascular medicine2023

Implantable cardioverter defibrillator for primary prevention in patients with non-ischemic cardiomyopathy in the era of novel therapeutic agents- meta-analysis.

Yotam Kolben et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.